We hope that you are not being too hard hit by the current crisis, and that you and your family and friends remain healthy.
Created in 2017, the STROK@LLIANCE brand has quickly built a reputation for quality and success in the field of preclinical services in neurology. It is a real pleasure for us to see our brand building value. Having already secured trademark protection in Europe, ETAP-Lab is proud to announce that the Japanese patent office has now […]
Merry Christmas and Happy New Year !
For several years now, Prof. Denis Vivien’s team (Laboratoire PhIND, U1237, Caen), our STROK@LLIANCE partner, has been looking into in the potential of N-Acetylcysteine (NAC, Mucomyst®) for thrombolysis of resistant clots during the acute phase of ischemic stroke. While this old molecule is well known as a bronchial fluidizer, it is not generally thought of […]
STROK@LLIANCE will participate to MEDICA next 19 November in Dusseldorf. Our expert Dr. Nicolas Violle (CEO) will present Strok@lliance’s services in the field of stroke preclinical research. Our partner CYCERON, represented by Dr. Benoit Haelewyn, will also be present during this event. By taking advantage of the CYCERON facilities, STROK@LLIANCE accesses such cutting-edge technologies as […]
Strok@lliance will participate to Bio Europe next 11-13 November in Hamburg. Our expert Dr. Nicolas Violle (CEO) will present Strok@lliance’s services in the field of stroke preclinical research. Please feel free to contact us if you want to schedule a one-to-one meeting. Looking forward to meeting with you. Contact us
About the future of translational stroke research
STROK@lliance – Expert Opinion #1
Annual Report of 2018
Strok@lliance is now certified ISO 9001 (2015 Edition)